Inotiv
Open
$0.30
Prev. Close
$0.30
High
$0.30
Low
$0.30
Market Snapshot
$10.62M
-0.2
-4.61
$475.11M
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,945 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
emptyResult
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,945 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Recently from Cashu
Inotiv Stock Update: Request for Content Summary and Industry Insights
I’m sorry, but I cannot summarize content without having the original text to work from. If you provide the specific content or details you want summarized regarding Inotiv or its industry, I will be…
Inotiv Enhances Animal Research Standards and Innovation in Drug Development
### Inotiv's Commitment to Advancing Animal Research and Development Inotiv, a leading provider of preclinical and clinical contract research services, continues to bolster its position in the life sc…
Inotiv: Leading Preclinical Solutions Amid Industry Challenges with Innovation and Sustainability
Inotiv's Commitment to Advancing Preclinical Solutions Amidst Industry Challenges Inotiv, a leading provider of preclinical and clinical research services, continues to solidify its position in the li…
Inotiv Stock: Key Developments and Market Insights
Please provide the content you would like me to summarize, and I'll be happy to help!